The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Hyaluronan-CD44 Interaction with Protein Kinase Cϵ Promotes Oncogenic Signaling by the Stem Cell Marker Nanog and the Production of MicroRNA-21, Leading to Down-regulation of the Tumor Suppressor Protein PDCD4, Anti-apoptosis, and Chemotherapy Resistance in Breast Tumor Cells
Open accessAbstract
Multidrug resistance and disease relapse is a challenging clinical problem in the treatment of breast cancer. In this study, we investigated the hyaluronan (HA)-induced interaction between CD44 (a primary HA receptor) and protein kinase Cepsilon (PKCepsilon), which regulates a number of human breast tumor cell functions. Our results indicate that HA binding to CD44 promotes PKCepsilon activation, which, in turn, increases the phosphorylation of the stem cell marker, Nanog, in the breast tumor cell line MCF-7. Phosphorylated Nanog is then translocated from the cytosol to the nucleus and becomes associated with RNase III DROSHA and the RNA helicase p68. This process leads to microRNA-21 (miR-21) production and a tumor suppressor protein (e.g. PDCD4 (program cell death 4)) reduction. All of these events contribute to up-regulation of inhibitors of apoptosis proteins (IAPs) and MDR1 (multidrug-resistant protein), resulting in anti-apoptosis and chemotherapy resistance. Transfection of MCF-7 cells with PKCepsilon or Nanog-specific small interfering RNAs effectively blocks HA-mediated PKCepsilon-Nanog signaling events, abrogates miR-21 production, and increases PDCD4 expression/eIF4A binding. Subsequently, this PKCepsilon-Nanog signaling inhibition causes IAP/MDR1 down-regulation, apoptosis, and chemosensitivity. To further evaluate the role of miR-21 in oncogenesis and chemoresistance, MCF-7 cells were also transfected with a specific anti-miR-21 inhibitor in order to silence miR-21 expression and inhibit its target functions. Our results indicate that anti-miR-21 inhibitor not only enhances PDCD4 expression/eIF4A binding but also blocks HA-CD44-mediated tumor cell behaviors. Thus, this newly discovered HA-CD44 signaling pathway should provide important drug targets for sensitizing tumor cell apoptosis and overcoming chemotherapy resistance in breast cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
MicroRNA genes are transcribed by RNA polymerase II
Lee, Y., Kim, M., Han, J., Yeom, K., Lee, S., Baek, S. H., & Kim, V. N. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600385 · Cited by 4,373
ABC Transporters: From Microorganisms to Man
Higgins, C. F. (1992) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.08.110192.000435 · Cited by 3,985
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
Juliano, R. L., & Ling, V. (1976) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(76)90160-7 · Cited by 3,296
Functional Expression Cloning of Nanog, a Pluripotency Sustaining Factor in Embryonic Stem Cells
Chambers, I., Colby, D., Robertson, M., Nichols, J., Lee, S., Tweedie, S., & Smith, A. (2003) · Cell · doi:10.1016/s0092-8674(03)00392-1 · Cited by 3,255
The Homeoprotein Nanog Is Required for Maintenance of Pluripotency in Mouse Epiblast and ES Cells
Mitsui, K., Tokuzawa, Y., Itoh, H., Segawa, K., Murakami, M., Takahashi, K., Maruyama, M., Maeda, M., & Yamanaka, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00393-3 · Cited by 3,191
MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer
Meng, F., Henson, R., Wehbe–Janek, H., Ghoshal, K., Jacob, S. T., & Patel, T. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.022 · Cited by 2,773
Proliferation, cell cycle and apoptosis in cancer
Evan, G. I., & Vousden, K. H. (2001) · Nature · doi:10.1038/35077213 · Cited by 2,724
MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells
Chan, J. A., Krichevsky, A. M., & Kosik, K. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0137 · Cited by 2,557
Control of translation and mRNA degradation by miRNAs and siRNAs: Table 1.
Valencia-Sanchez, M. A., Liu, J., Hannon, G. J., & Parker, R. (2006) · Genes & Development · doi:10.1101/gad.1399806 · Cited by 2,060
Asangani, I. A., Rasheed, S. A. K., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S., & Allgayer, H. (2008) · Oncogene · doi:10.1038/sj.onc.1210856 · Cited by 1,882
Laurent, T. C., & Fraser, J. R. E. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.7.1563592 · Cited by 1,880
CAI, X., HAGEDORN, C. H., & CULLEN, B. R. (2004) · RNA · doi:10.1261/rna.7135204 · Cited by 1,872
Si, M.-L., Zhu, S., Wu, H., Lu, Z., Wu, F., & Mo, Y.-Y. (2007) · Oncogene · doi:10.1038/sj.onc.1210083 · Cited by 1,600
Expression of a multidrug-resistance gene in human tumors and tissues.
Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M., & Pastan, I. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.1.265 · Cited by 1,544
MicroRNAs Regulate Brain Morphogenesis in Zebrafish
Giraldez, A. J., Cinalli, R. M., Glasner, M. E., Enright, A. J., Thomson, J. M., Baskerville, S., Hammond, S. M., Bartel, D. P., & Schier, A. F. (2005) · Science · doi:10.1126/science.1109020 · Cited by 1,315
(2005) · doi:10.1093/nar/gki200 · Cited by 1,208
Frankel, L. B., Christoffersen, N. R., Jacobsen, A., Lindow, M., Krogh, A., & Lund, A. H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707224200 · Cited by 1,141
Transcriptional Regulation of Nanog by OCT4 and SOX2
Rodda, D. J., Chew, J.-L., Lim, L.-H., Loh, Y.-H., Wang, B., Ng, H.-H., & Robson, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502573200 · Cited by 1,140
Modulation of microRNA processing by p53
Suzuki, H. I., Yamagata, K., Sugimoto, K., Iwamoto, T., Kato, S., & Miyazono, K. (2009) · Nature · doi:10.1038/nature08199 · Cited by 1,124
Gros, P., Croop, J., & Housman, D. (1986) · Cell · doi:10.1016/0092-8674(86)90594-5 · Cited by 1,031
Screaton, G. R., Bell, M. V., Jackson, D. G., Cornelis, F. B., Gerth, U., & Bell, J. I. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12160 · Cited by 1,015
The inhibitors of apoptosis (IAPs) and their emerging role in cancer
LaCasse, E. C., Baird, S., Korneluk, R. G., & MacKenzie, A. E. (1998) · Oncogene · doi:10.1038/sj.onc.1202569 · Cited by 982
Peltier, H. J., & Latham, G. J. (2008) · RNA · doi:10.1261/rna.939908 · Cited by 820
Hyaluronidases: Their Genomics, Structures, and Mechanisms of Action
Stern, R., & Jedrzejas, M. J. (2006) · Chemical Reviews · doi:10.1021/cr050247k · Cited by 804
MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene
Lu, Z., Liu, M., Stribinskis, V, Klinge, C. M., Ramos, K. S., Colburn, N. H., & Li, Y. (2008) · Oncogene · doi:10.1038/onc.2008.72 · Cited by 711
Weigel, P. H., Hascall, V. C., & Tammi, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.22.13997 · Cited by 628
The inhibitors of apoptosis (IAPs) as cancer targets
Hunter, A. M., LaCasse, E. C., & Korneluk, R. G. (2007) · Apoptosis · doi:10.1007/s10495-007-0087-3 · Cited by 565
Laurent, T. C., & Fraser, J. R. E. (1992) · PubMed · Cited by 550
Unwinding RNA in Saccharomyces cerevisiae: DEAD-box proteins and related families
de la Cruz, J., Kressler, D., & Linder, P. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01376-6 · Cited by 528
Hyaluronan: a multifunctional, megaDalton, stealth molecule
Lee, J. Y., & Spicer, A. P. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00135-6 · Cited by 525
Yang, H.-S., Jansen, A. P., Komar, A. A., Zheng, X., Merrick, W. C., Costes, S., Lockett, S. J., Sonenberg, N., & Colburn, N. H. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.26-37.2003 · Cited by 494
Hyaluronan-Cell Interactions in Cancer and Vascular Disease
Toole, B. P., Wight, T. N., & Tammi, M. I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100039200 · Cited by 491
Octamer and Sox Elements Are Required for Transcriptional cis Regulation of Nanog Gene Expression
Kuroda, T., Tada, M., Kubota, H., Kimura, H., Hatano, S.-Y., Suemori, H., Nakatsuji, N., & Tada, T. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.6.2475-2485.2005 · Cited by 486
Bourguignon, L. Y. W., Peyrollier, K., Xia, W., & Gilad, E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800109200 · Cited by 442
Self-citationEzeh, U. I., Turek, P. J., Reijo, R. A., & Clark, A. T. (2005) · Cancer · doi:10.1002/cncr.21432 · Cited by 425
Bourguignon, L. Y. W., Singleton, P. A., Diedrich, F., Stern, R., & Gilad, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311838200 · Cited by 422
Self-citationStabel, S., & Parker, P. J. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90042-k · Cited by 408
Wickramasinghe, N. S., Manavalan, T. T., Dougherty, S. M., Riggs, K. A., Li, Y., & Klinge, C. M. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp117 · Cited by 391
Bourguignon, L. Y. W. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.007 · Cited by 305
Self-citationBourguignon, L. Y. W., Gunja-Smith, Z., Iida, N., Zhu, H. B., Young, L. J. T., Muller, W. J., & Cardiff, R. D. (1998) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199807)176:1<206::aid-jcp22>3.0.co;2-3 · Cited by 270
Self-citationBourguignon, L. W., Zhu, H., Shao, L., & Chen, Y.-W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006498200 · Cited by 262
Self-citationMisra, S., Ghatak, S., & Toole, B. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500737200 · Cited by 245
Screaton, G. R., Bell, M. V., Bell, J. I., & Jackson, D. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31376-0 · Cited by 243
A novel PKC-regulated mechanism controls CD44–ezrin association and directional cell motility
Legg, J. W., Lewis, C. A., Parsons, M., Ng, T., & Isacke, C. M. (2002) · Nature Cell Biology · doi:10.1038/ncb797 · Cited by 238
Bourguignon, L. Y. W., Zhu, H., Chu, A., Iida, N., Zhang, L., & Hung, M.-C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.27913 · Cited by 237
Self-citationBourguignon, L. Y. W., Singleton, P. A., Zhu, H., & Diedrich, F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301885200 · Cited by 237
Self-citationBourguignon, L. Y. W., Singleton, P. A., Zhu, H., & Zhou, B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204320200 · Cited by 224
Self-citationRegulation of Multidrug Resistance in Cancer Cells by Hyaluronan
Misra, S., Ghatak, S., Zoltan-Jones, A., & Toole, B. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300173200 · Cited by 221
Hyaluronan on the surface of tumor cells is correlated with metastatic behavior.
Zhang, L., Underhill, C. B., & Chen, L. (1995) · PubMed · Cited by 211
The CD44 Receptor Interacts with P-Glycoprotein to Promote Cell Migration and Invasion in Cancer
Miletti-González, K. E., Chen, S., Muthukumaran, N., Saglimbeni, G. N., Wu, X., Yang, J., Apolito, K., Shih, W. J., Hait, W. N., & Rodrı́guez-Rodrı́guez, L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3478 · Cited by 207
Bourguignon, L. Y. W., Zhu, H., Zhou, B., Diedrich, F., Singleton, P. A., & Hung, M.-C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106759200 · Cited by 188
Self-citationPardo, O. E., Wellbrock, C., Khanzada, U. K., Aubert, M., Arozarena, I., Davidson, S., Bowen, F., Parker, P. J., Filonenko, V. V., Gout, I. T., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601198 · Cited by 183
Protein Kinase C Isozymes as Potential Targets for Anticancer Therapy
Hofmann, J. (2004) · Current Cancer Drug Targets · doi:10.2174/1568009043481579 · Cited by 176
Bourguignon, L. Y. W., Xia, W., & Wong, G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806708200 · Cited by 173
Self-citationCOWLAND, J. B., HOTHER, C., & GRØNBÆK, K. (2007) · APMIS · doi:10.1111/j.1600-0463.2007.apm_775.xml.x · Cited by 166
PDCD4 inhibits translation initiation by binding to eIF4A using both its MA3 domains
Suzuki, C., Garces, R. G., Edmonds, K. A., Hiller, S., Hyberts, S. G., Marintchev, A., & Wagner, G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712235105 · Cited by 165
Bourguignon, L., Zhu, H., Shao, L., Zhu, D., & Chen, Y.-W. (1999) · Cell Motility and the Cytoskeleton · doi:10.1002/(sici)1097-0169(1999)43:4<269::aid-cm1>3.0.co;2-5 · Cited by 158
Self-citationWang, S. J., & Bourguignon, L. (2006) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.132.7.771 · Cited by 157
Self-citationExpression Cloning and Molecular Characterization of HAS Protein, a Eukaryotic Hyaluronan Synthase
Itano, N., & Kimata, K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.17.9875 · Cited by 154
CD44-Mediated Oncogenic Signaling and Cytoskeleton Activation During Mammary Tumor Progression
Bourguignon, L. (2001) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1011371523994 · Cited by 152
Self-citationProtein kinase Cε: an oncogene and emerging tumor biomarker
Gorin, M. A., & Pan, Q. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-9 · Cited by 140
New CD44 splice variants associated with human breast cancers
Iida, N., & Bourguignon, L. (1995) · Journal of Cellular Physiology · doi:10.1002/jcp.1041620115 · Cited by 137
Self-citationNANOGP8 is a retrogene expressed in cancers
Zhang, J., Wang, X., Li, M., Han, J., Chen, B., Wang, B., & Dai, J. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05186.x · Cited by 134
Structural basis for translational inhibition by the tumour suppressor Pdcd4
Loh, P. G., Yang, H., Walsh, M. A., Wang, Q., Wang, X., Cheng, Z., Liu, D. X., & Song, H. (2009) · The EMBO Journal · doi:10.1038/emboj.2008.278 · Cited by 128
Salzman, D. W., Shubert-Coleman, J., & Furneaux, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705054200 · Cited by 121
Kalomiris, E. L., & Bourguignon, L. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83157-x · Cited by 113
Self-citationProtein kinase C: a target for anticancer drugs?
MacKay, H. J., & Twelves, C. J. (2003) · Endocrine Related Cancer · doi:10.1677/erc.0.0100389 · Cited by 104
Roles of Multidrug Resistance Genes in Breast Cancer Chemoresistance
Kuo, M. T. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-74039-3_2 · Cited by 102
Bourguignon, L., Lokeshwar, V. B., He, J. Z., Chen, X., & Bourguignon, G. J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.10.4464 · Cited by 96
Self-citationThe Role of Hyaluronic Acid in Hemopoietic Stem Cell Biology
Haylock, D. N., & Nilsson, S. K. (2006) · Regenerative Medicine · doi:10.2217/17460751.1.4.437 · Cited by 94
Interaction between CD44 and hyaluronate induces chemoresistance in non-small cell lung cancer cell
Ohashi, R., Takahashi, F., Cui, R., Yoshioka, M., Gu, T., Sasaki, S., Tominaga, S., Nishio, K., Tanabe, K. K., & Takahashi, K. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.025 · Cited by 89
Russo, R. I. C., García, M. G., Alaniz, L. D., Blanco, G. A. C., Álvarez, É., & Hajos, S. E. (2007) · International Journal of Cancer · doi:10.1002/ijc.23122 · Cited by 88
Serum hyaluronan (hyaluronic acid) in breast cancer patients
Delpech, B., Chevallier, B., Reinhardt, N., Julien, J., Duval, C., Maingonnat, C., Bastit, P., & Asselain, B. J. R. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910460309 · Cited by 79
Mammalian hyaluronan synthases: investigation of functional relationships in vivo
Spicer, A. P., & Nguyen, T. (1999) · Biochemical Society Transactions · doi:10.1042/bst0270109 · Cited by 69
Iida, N., & Bourguignon, L. (1997) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199705)171:2<152::aid-jcp5>3.0.co;2-n · Cited by 66
Self-citationSteinberg, R., Harari, O., Lidington, E. A., Boyle, J. J., Nohadani, M., Samarel, A. M., Ohba, M., Haskard, D. O., & Mason, J. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704001200 · Cited by 63
Study of suboptimum treatment response: lessons from breast cancer
Lønning, P. E. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01022-2 · Cited by 57
Wang, S. J., & Bourguignon, L. (2006) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.132.1.19 · Cited by 54
Self-citationMDR1, Chemotherapy and chromatin remodeling
Baker, E. K., & El‐Osta, A. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.9.1101 · Cited by 48
Protein kinase C-ε protects MCF-7 cells from TNF-mediated cell death by inhibiting Bax translocation
Lu, D., Sivaprasad, U., Huang, J., Shankar, E., Morrow, S., & Basu, A. (2007) · APOPTOSIS · doi:10.1007/s10495-007-0111-7 · Cited by 38
Chuthapisith, S., Eremin, J., ElSheemy, M. S., & Eremin, O. (2006) · The Surgeon · doi:10.1016/s1479-666x(06)80062-4 · Cited by 28
Cell-Cell Fusion as a Means to Establish Pluripotency
Do, J. T., & Schöler, H. R. (2006) · Springer eBooks · doi:10.1007/3-540-31437-7_4 · Cited by 23
Hyaluronan Synthase: New Directions for Hyaluronan Research.
Itano, N., & Kimata, K. (1998) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.10.23 · Cited by 19
Early and Late Events in the Development of Human Breast Cancer
Smith, H. S., Stern, R., Liu, E., & Benz, C. C. (1991) · Springer eBooks · doi:10.1007/978-1-4684-5994-4_27 · Cited by 8
Cited by
CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
Zöller, M. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3023 · Cited by 1,112
Misra, S., Hascall, V. C., Markwald, R. R., & Ghatak, S. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00201 · Cited by 830
The role and mechanisms of action of microRNAs in cancer drug resistance
Si, W., Shen, J., Zheng, H., & Fan, W. (2019) · Clinical Epigenetics · doi:10.1186/s13148-018-0587-8 · Cited by 668
Yan, Y., Zuo, X., & Wei, D. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0048 · Cited by 633
Hyaluronan: molecular size‐dependent signaling and biological functions in inflammation and cancer
Tavianatou, A. G., Caon, I., Franchi, M., Piperigkou, Z., Galesso, D., & Karamanos, N. K. (2019) · The FEBS Journal · doi:10.1111/febs.14777 · Cited by 462
Metadata
- Authors
- Bourguignon, L. Y. W., Spevak, C. C., Wong, G., Xia, W., & Gilad, E.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 284
- Issue
- 39
- Pages
- 26533-26546
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1983985456
- Cited by
- 316
- References
- 86
- FWCI
- 11.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.